Continuous infusion versus intermittent administration of meropenem in critically ill patients.
about
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infectionsPopulation pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.Antifungal pharmacodynamics: review of the literature and clinical applications.Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.Nonlinear pharmacokinetics of piperacillin in healthy volunteers--implications for optimal dosage regimensClinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis.Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapyAntibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.Short versus long infusion of meropenem in very-low-birth-weight neonatesDoes Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Pharmacodynamics of antimicrobials: treatment optimisation.The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.Pharmacodynamic optimization of beta-lactams in the patient care setting.Pharmacokinetic and pharmacodynamic properties of meropenem.Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study.The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Optimization of meropenem dosage in the critically ill population based on renal function.Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients.Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation.Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study.Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients.Temporary interruption of ceftazidime continuous infusion without reduction of activity: a computer-assisted simulation.Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem.Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem.Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis.Comparative pharmacokinetics and pharmacodynamics of doripenem and meropenem in obese patients.Steady-state pharmacokinetics and pharmacodynamics of meropenem in morbidly obese patients hospitalized in an intensive care unit.
P2860
Q24199096-E6E31AC0-988A-4717-A9A3-956F61808EA8Q30316322-6EDCF35D-FCAA-4B84-86D2-824621B9F152Q33722108-9E74C06E-C29C-49E4-8444-EC2C25EC2C2DQ33770046-B299FD7E-E59B-4A3D-846D-E5005707DAD4Q34083129-8EB5842F-5A20-4EA6-B576-68EA72359B6FQ34111057-CB3CFD67-838D-4427-B5B7-DF2432F53A6BQ34153182-730E0D81-BEE1-49F4-9DC2-371805826875Q34381321-A0B54C1B-92AE-44B4-B5D2-4FE264E4B371Q34892334-19C56715-586A-42F5-817E-3A4F829F13C6Q35558292-2CC94F38-CE32-432B-B6BB-5FF71CE8891BQ35908084-CAD685DC-EC09-4D76-900B-5975D41C02F2Q36172523-46AC28B3-85E6-4B77-9049-AC127FB7976DQ36287127-212C0ED1-4F93-4172-BE18-85A8512DC8FCQ36505518-70E7DF40-8170-4F90-92B7-DB9C7A18927EQ36544935-4CDE9387-B9B9-44D7-B9B7-01FEC07D8CE5Q37098999-26E133FB-30D3-46BB-9BF0-4743EC2D5992Q37169843-C679B675-1832-4E2E-A175-52BFDE8C85A6Q37247125-CF76F319-6A4B-4CB5-90F6-EE827D084402Q37364236-476ABC54-F79C-427B-B3C8-51754931602BQ37933418-F53C8227-FD92-427B-AB97-4DC17494B9D9Q38107537-B5B16B0E-72AB-42B7-8B6E-E5301CFED64AQ38167345-95EC6D04-00F7-400D-B9C0-09D207791B82Q38896040-56E968AF-01A4-41B8-AB9E-C3386C0178FFQ39961839-D42CBB1E-EA57-4A22-9CEB-51215F194FBCQ40727311-61BC14FE-E959-423C-92D2-7A641A8BE5E4Q40732203-29278F36-3D11-499C-8D32-642616CE152BQ42247410-BBC85EE3-B900-4D9B-AC8B-C8014FE68D71Q42656891-CC541174-BF29-4FD2-8B92-D975B039C127Q43758472-E6E71F9B-9B46-470C-ACF5-C34945AF4DB0Q44601141-0826974F-21A8-42D1-9456-CF32C2857A5DQ46034494-0FCEEB8B-66B9-410E-8547-9E828626EB80Q46592051-D16AF7AB-4550-4C43-B335-FA2C74B5D3B7Q46921577-995F6BC1-8F91-46C8-B59E-4D091B4920DBQ47745708-521BFBEE-B72E-43A2-B22F-BD4E085F1267Q54561986-6D2AAA9E-DD51-4816-BC62-62E547C48486Q54766719-4FC470F3-954A-41A0-81DE-20EF04D00D1A
P2860
Continuous infusion versus intermittent administration of meropenem in critically ill patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Continuous infusion versus int ...... em in critically ill patients.
@en
Continuous infusion versus int ...... em in critically ill patients.
@nl
type
label
Continuous infusion versus int ...... em in critically ill patients.
@en
Continuous infusion versus int ...... em in critically ill patients.
@nl
prefLabel
Continuous infusion versus int ...... em in critically ill patients.
@en
Continuous infusion versus int ...... em in critically ill patients.
@nl
P2093
P356
P1476
Continuous infusion versus int ...... em in critically ill patients.
@en
P2093
Burgmann H
El Menyawi I
Hollenstein UM
Staudinger T
Thalhammer F
Thalhammer-Scherrer R
Traunmüller F
P304
P356
10.1093/JAC/43.4.523
P407
P577
1999-04-01T00:00:00Z